Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 22.41
+0.03 (0.13%)
Aug 20, 2026, 3:04 PM CST
SHE:300702 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 7,707 | 8,117 | 5,730 | 7,555 | 8,880 | 16,825 | |
Market Cap Growth | -18.30% | 41.66% | -24.15% | -14.93% | -47.22% | -1.25% |
Enterprise Value | 8,914 | 9,495 | 6,950 | 8,887 | 9,411 | 16,765 |
Last Close Price | 22.41 | 23.54 | 16.58 | 21.55 | 25.34 | 47.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 79.79 | 58.10 | 102.44 | 276.13 | - | 82.20 |
Forward PE | 24.63 | 25.79 | 34.35 | 33.57 | 51.04 | 17.99 |
PS Ratio | 2.48 | 2.65 | 2.18 | 2.99 | 3.33 | 6.61 |
PB Ratio | 2.09 | 2.23 | 1.64 | 2.17 | 2.54 | 4.54 |
P/TBV Ratio | 2.38 | 2.55 | 1.86 | 2.43 | 2.84 | 5.05 |
P/FCF Ratio | 35.12 | 70.09 | 32.61 | - | - | - |
P/OCF Ratio | 13.09 | 17.14 | 16.63 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.86 | 3.10 | 2.64 | 3.52 | 3.53 | 6.59 |
EV/EBITDA Ratio | 16.71 | 17.23 | 16.02 | 20.21 | 57.19 | 45.18 |
EV/EBIT Ratio | 52.26 | 46.62 | 62.56 | 60.83 | - | 90.21 |
EV/FCF Ratio | 40.62 | 82.00 | 39.56 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.48 | 0.49 | 0.53 | 0.52 | 0.37 | 0.17 |
Debt / EBITDA Ratio | 3.33 | 3.16 | 4.13 | 3.99 | 7.34 | 1.68 |
Debt / FCF Ratio | 8.11 | 15.29 | 10.45 | - | - | - |
Net Debt / Equity Ratio | 0.33 | 0.35 | 0.36 | 0.39 | 0.23 | 0.02 |
Net Debt / EBITDA Ratio | 2.30 | 2.28 | 2.87 | 3.12 | 4.92 | 0.24 |
Net Debt / FCF Ratio | 5.50 | 10.86 | 7.08 | -3.80 | -1.41 | -0.09 |
Asset Turnover | 0.48 | 0.47 | 0.41 | 0.40 | 0.44 | 0.48 |
Inventory Turnover | 1.22 | 1.11 | 0.93 | 0.86 | 1.15 | 1.26 |
Quick Ratio | 0.52 | 0.47 | 0.42 | 0.40 | 0.35 | 0.56 |
Current Ratio | 1.19 | 1.15 | 1.09 | 1.15 | 1.13 | 1.51 |
Return on Equity (ROE) | 2.63% | 3.91% | 1.60% | 0.78% | -3.30% | 5.64% |
Return on Assets (ROA) | 1.65% | 1.93% | 1.07% | 1.43% | -0.81% | 2.17% |
Return on Invested Capital (ROIC) | 3.06% | 3.72% | 1.65% | 1.21% | -1.97% | 5.54% |
Return on Capital Employed (ROCE) | 4.30% | 5.10% | 3.00% | 3.90% | -2.10% | 4.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.24% | 1.72% | 0.98% | 0.36% | -1.34% | 1.22% |
FCF Yield | 2.85% | 1.43% | 3.07% | -4.78% | -6.48% | -5.93% |
Dividend Yield | 0.22% | 0.21% | 0.30% | 0.23% | - | 0.21% |
Payout Ratio | 58.45% | 41.49% | 125.49% | 186.83% | - | 54.93% |
Buyback Yield / Dilution | 2.50% | 2.53% | -2.22% | 2.18% | -0.78% | -6.61% |
Total Shareholder Return | 2.73% | 2.74% | -1.92% | 2.42% | -0.78% | -6.40% |